Interactions between cell death induced by statins and 7‐ketocholesterol in rabbit aorta smooth muscle cells
- 1 July 2008
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 154 (6), 1236-1246
- https://doi.org/10.1038/bjp.2008.181
Abstract
7-Ketocholesterol, an oxysterol present in atherosclerotic lesions, induces smooth muscle cell (SMC) death, thereby destabilizing plaques. Statins protect patients from myocardial infarction, though they induce SMC apoptosis. We investigated whether statins and 7-ketocholesterol exerted additive cell death effects. Cultured rabbit aorta SMCs (passage 2-6) were exposed to 7-ketocholesterol with or without fluvastatin, simvastatin or pravastatin. Uptake of neutral red (NR), monolayer protein, cleavage of the pan-caspase substrate Asp-Glu-Val-Asp-rhodamine110, cell morphology (light and electron microscopy) and processing of microtubule-associated protein 1 light chain 3 (LC3, immunoblot) were determined. NR uptake declined upon 18 h exposure to 25 microM 7-ketocholesterol (-41+/-3%, n=13), 100 microM fluvastatin (-59%) or 30-100 microM simvastatin (-28 to -74%). Oxysterol and high statin concentrations exerted additive effects, but lower concentrations (fluvastatin 10-30 microM, simvastatin 1-10 microM) partly reversed viability loss. 7-Ketocholesterol caused intense cytoplasmic vacuolization, processing of LC3-I to LC3-II, but little caspase activation (increase 29.5%). Fluvastatin (10-100 microM, 70-545% increase) and simvastatin (3-100 microM 43-322% increase) induced caspase activation without LC3 processing, but failed to activate caspases in 7-ketocholesterol-treated SMCs. Pravastatin up to 100 microM was always inactive. 7-Ketocholesterol caused SMC death, mainly via autophagic vesicle formation with LC3 processing, whereas lipophilic statins evoked SMC apoptosis. Cell death following 7-ketocholesterol and low statin concentrations were not additive, presumably because the autophagic process interfered with statin-induced caspase activation. This further illustrates that drug effects in normal SMCs are not necessarily predictive for activities in atherosclerotic settings.Keywords
This publication has 33 references indexed in Scilit:
- Does Autophagy Contribute To Cell Death?Autophagy, 2005
- 7-Ketocholesterol Induces Protein Ubiquitination, Myelin Figure Formation, and Light Chain 3 Processing in Vascular Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- 7-Ketocholesterol induces reversible cytochrome c release in smooth muscle cells in absence of mitochondrial swellingCardiovascular Research, 2004
- Autophagy as a cell death and tumor suppressor mechanismOncogene, 2004
- Oxysterol-Induced Apoptosis of Vascular Smooth Muscle Cells is Reduced by HMG-CoA Reductase Inhibitor, PravastatinJournal of Atherosclerosis and Thrombosis, 2002
- Lessons From Sudden Coronary DeathArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- PROAPOPTOTIC EFFECT OF ATORVASTATIN ON STIMULATED RABBIT SMOOTH MUSCLE CELLSPharmacological Research, 1997
- Simvastatin Modulates the Heat Shock Response and Cytotoxicity Mediated by Oxidized LDL in Cultured Human Endothelial Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1997
- Oxysterols Induced Apoptosis in Cultured Smooth Muscle Cells through CPP32 Protease Activation and bcl-2 Protein DownregulationBiochemical and Biophysical Research Communications, 1996
- Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductaseAtherosclerosis, 1993